GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of BCLI
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

High volatility in Brainstorm Cell Therapeutics Inc. stock price on Thursday which ended trading at $0.514
(Updated on Apr 18, 2024)

Buy or Hold candidate since Mar 19, 2024 Gain 44.59% PDF

The Brainstorm Cell Therapeutics Inc. stock price fell by -4.90% on the last day (Thursday, 18th Apr 2024) from $0.541 to $0.514. During the last trading day the stock fluctuated 30.76% from a day low at $0.451 to a day high of $0.590. The price has fallen in 6 of the last 10 days and is down by -23.81% for this period. Volume has increased on the last day by 553 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 1 million shares were bought and sold for approximately $554.95 thousand.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.447 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 69.98% during the next 3 months and, with a 90% probability hold a price between $0.759 and $1.38 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

BCLI Signals & Forecast

The Brainstorm Cell Therapeutics Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $0.556. On a fall, the stock will find some support from the long-term average at approximately $0.499. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, April 01, 2024, and so far it has fallen -30.49%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Brainstorm Cell Therapeutics Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Brainstorm Cell Therapeutics Inc. stock

Brainstorm Cell Therapeutics Inc. finds support from accumulated volume at $0.507 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.139 between high and low, or 30.76%. For the last week, the stock has had daily average volatility of 17.49%.

Our recommended stop-loss: $0.488 (-5.08%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 13 days ago.)

Trading Expectations (BCLI) For The Upcoming Trading Day Of Friday 19th

For the upcoming trading day on Friday, 19th we expect Brainstorm Cell Therapeutics Inc. to open at $0.519, and during the day (based on 14 day Average True Range), to move between $0.424 and $0.605, which gives a possible trading interval of +/-$0.0905 (+/-17.60%) up or down from last closing price. If Brainstorm Cell Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 35.20% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.507 (1.42%) than the resistance at $0.570 (10.83%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Brainstorm Cell Therapeutics Inc. stock A Buy?

Brainstorm Cell Therapeutics Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

Current score: 0.768 Hold/Accumulate Downgraded

Predicted Opening Price for Brainstorm Cell Therapeutics Inc. of Friday, April 19, 2024

Fair opening price April 19, 2024 Current price
$0.519 ( 0.82%) $0.514

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for BCLI

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.657 27.80 %
R2 0.604 17.50 %
R1 0.572 11.13 %
Current price: 0.514
Support S1 0.465 -9.49 %
S2 0.433 -15.86 %
S3 0.380 -26.17 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.583 13.26 %
R2 0.577 12.21 %
R1 0.570 10.83 %
Current price 0.514
Support S1 0.507 -1.42%
S2 0.394 -23.49%
S3 0.390 -24.17%

FAQ

What is the symbol for Brainstorm Cell Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Brainstorm Cell Therapeutics Inc. is BCLI and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Brainstorm Cell Therapeutics Inc. Stock?
Brainstorm Cell Therapeutics Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

How to buy Brainstorm Cell Therapeutics Inc. Stock?
Brainstorm Cell Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Brainstorm Cell Therapeutics Inc. Stock.

What's the current price of Brainstorm Cell Therapeutics Inc. Stock?
As of the end of day on the 2024-04-18, the price of an Brainstorm Cell Therapeutics Inc. (BCLI) share was $0.514.

What is the 52-week high and low for Brainstorm Cell Therapeutics Inc. Stock?
The 52-week high for Brainstorm Cell Therapeutics Inc. Stock is $3.35 and the 52-week low is $0.135.

What is the market capitalization of Brainstorm Cell Therapeutics Inc. Stock?
As of the 2024-04-18, the market capitalization of Brainstorm Cell Therapeutics Inc. is 36.959M.

When is the next earnings date for Brainstorm Cell Therapeutics Inc.?
The upcoming earnings date for Brainstorm Cell Therapeutics Inc. is May 20, 2024.
Click to get the best stock tips daily for free!

About Brainstorm Cell Therapeutics Inc.

Brainstorm Cell Therapeutics. Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative ... BCLI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT